Dermatology — Specialty Profile

Exploratory, not prescriptive. This profile blends hard data (pay, match rates, burnout, demographics — each sourced and dated) with generalizations and synthesized online opinion about culture and "who fits." It's here to help you get curious and go find out for yourself — not to tell you who to become. Numbers marked ⟳ verify change every year; check the linked source before you quote one. Last reviewed: 2026-07-25.

Also called: derm, skin. A residency you match into as an "advanced" position (you do a separate intern year first). Organ system: skin, hair, and nails, the body's largest organ and the window onto a lot of internal disease.

The 30-second version

Dermatology is the specialty of the skin, hair, and nails, a field where you diagnose largely by looking, treat a huge range of disease from acne to melanoma, and do most of your procedures awake, in-office, under local anesthesia. You read morphology the way a cardiologist reads an EKG; you biopsy and excise skin cancers (the most common cancer in the US); you manage serious inflammatory and autoimmune disease with a new generation of biologic drugs; and, if you want, you run a cash-pay cosmetic practice on the side. Then you go home: no overnight call for most derms, no crashing patients at 3 a.m., a genuinely controllable week. That combination of top-tier pay earned in relatively few hours, with below-average burnout and unusually high work-life balance, is why derm is the "D" in the classic ROAD-to-lifestyle mnemonic, and why it is also one of the single hardest specialties in all of medicine to match into.

Quick dashboard (details and sources below)
Training after med school 4 years (1 intern year + 3 years derm)
Total from college start ~12 years (4 undergrad + 4 med school + 4 training)
Competitiveness Very high — among the hardest specialties to match ⟳
Typical full-time pay ~$450,000–$510,000 total comp ⟳
Pay range (structure) academic ~$436k · solo private ~$658k · partner ~$667k · Mohs ~$710k ⟳
Lifestyle Outpatient, appointment-driven, minimal-to-no call — one of medicine's most controllable
Burnout 31.5% against a 41.9% all-physician average (AMA 2025) — one of the six lowest rows it publishes ⟳
% women 53% practicing (2022); 65.3% of residents (AY2024-25) ⟳
DO / IMG accessibility Among the least open fields (~7% DO of positions; near-zero IMG) ⟳

What they actually do

Dermatologists diagnose and treat disorders of the skin, hair, and nails, a scope that runs from the trivial-looking to the life-threatening. The defining skill is visual pattern recognition: much of the field is a morphology discipline, where the diagnosis is made by inspecting a lesion, feeling its texture, and mapping its distribution, often confirmed with a punch or shave biopsy read under the microscope. Derm is unusual in medicine for spanning three modes of practice at once: cognitive diagnosis, hands-on procedures, and, for those who train in it, pathology.

The bread and butter is far more than acne and rashes. Dermatologists are frontline cancer doctors: skin cancer is the most common cancer in the United States, and derms detect and treat melanomas and non-melanoma skin cancers every day. They manage serious autoimmune and inflammatory disease, including psoriasis, severe eczema, lupus, pemphigus, and hidradenitis suppurativa, increasingly with a revolution of biologic immunotherapies. They handle pediatric skin disease and genodermatoses, drug reactions, and true dermatologic emergencies (Stevens-Johnson syndrome, DRESS, necrotizing infections) that are rare but genuinely dangerous. And many blend in a cash-pay cosmetic practice of Botox, fillers, and lasers that operates outside the insurance system entirely.

Representative procedures: skin biopsy (punch, shave, excisional) · benign and malignant lesion excision · cryotherapy and electrodesiccation · Mohs micrographic surgery (acting as surgeon and pathologist in one sitting) · intralesional injections · phototherapy management · patch testing · cosmetic injectables (neurotoxins, fillers) · laser and light-based procedures.

A day in the life: predictable and appointment-driven. Most derms work outpatient clinic days, moving briskly through a schedule that can range from a handful of complex medical patients to a high-throughput board of 40–60+ short visits, punctuated by in-office procedures done under local anesthesia. There is very little that cannot wait until morning: outpatient derm carries minimal-to-no overnight call, and the inpatient consult burden falls mostly on academic/hospital-based derms.1

The training path & time to completion

Medical school (4 yrs) → 1 intern year → dermatology residency (3 yrs) → board-eligible with ABD.2

  • The intern year is separate. Most dermatology positions are entered as "advanced" (PGY-2 start), so applicants match a broad clinical intern year separately: a transitional year, or a preliminary first year in emergency medicine, family medicine, general surgery, internal medicine, OB/GYN, or pediatrics (psychiatry and pathology PGY-1 years are not accepted). A smaller number of programs offer categorical PGY-1 derm spots that fold the intern year in.2
  • The three derm years (PGY-2 to PGY-4): full-time ACGME-accredited training in clinical dermatology, dermatologic surgery, inpatient/outpatient consults, dermatopathology, and subspecialty rotations.2
  • Board: the American Board of Dermatology (ABD). Candidates pass four CORE Exams during residency, then the APPLIED Exam after, to earn certification. (The osteopathic route, formerly via AOBD, is now consolidated under the single ACGME/ABMS pathway.)2
  • Total from the start of college: ~12 years (4 + 4 + 4). Add ~1 year for most fellowships.

How competitive is it?

Dermatology is, cycle after cycle, one of the most competitive specialties in the entire Match, and the barrier is exactly the "hidden" context a premed would never pick up from a salary list. The lifestyle-and-pay reputation is real, which is precisely why the front door is so crowded.

The raw fill numbers look almost boring, because the field essentially never has empty seats:

  • 2025 Match: advanced (PGY-2) dermatology offered 524 positions across 148 programs, with just 1 unfilled → 99.8% filled; the small categorical PGY-1 slice (30 positions) filled 100%.3 ⟳
  • 2026 Match (NRMP): 546 PGY-2 positions across 156 programs, 1 unfilled → 545 filled (99.8%); 79.5% of positions went to US MD seniors.4 ⟳

The competition shows up not in fill rates but in who gets in and what it took:

  • Matched US-MD seniors: mean USMLE Step 2 CK ≈ 257 (2024), among the highest of any specialty. (Step 1 is now pass/fail, so Step 2 CK is the key numeric screen.)5 ⟳
  • A research arms race. Matched US-MD seniors averaged ~28 abstracts/presentations/publications (27.7) and ~6.4 research experiences, among the highest research counts of any field.5 ⟳
  • Prestige signaling runs hot: among matched US-MD seniors, 41% were AOA and ~42% attended a top-40 NIH-funded medical school, each roughly double the unmatched rate. The PhD gap is far wider than that: ~10% of matched seniors held one against 1.7% of the unmatched.5 ⟳
  • Applicant-to-position ratio ~1.5:1 historically (e.g., 2022: 834 applicants for 544 positions), and that understates the difficulty, because weaker applicants self-select out before ever applying.6 ⟳

How closed it is to DO and IMG applicants (name it squarely): dermatology has among the lowest DO and IMG representation of any specialty. Roughly 80% of positions go to US MD seniors; DOs fill only about 7% of derm positions (2024 NRMP), and IMGs are nearly absent: in 2025 PGY-1 derm, 0 US IMGs and 1 non-US IMG matched.37 By applicant match rate in the 2026 cycle, US MD seniors matched at ~59%, but US DO seniors at only ~30%, roughly half the MD rate, and non-US IMGs at ~14%.4 ⟳

The honest read: unlike a field that softened and opened up, derm has stayed a very high bar with a research/connections/away-rotation entry cost that falls hardest on applicants without a home derm department or funded research time (see the FLI angle).

Compensation — the robust version

Dermatology is a high-paying specialty, and critically, one of the best-paid on a per-hour basis, because derms typically work fewer hours than surgical or hospital-based peers (see Lifestyle).8 It's also unusually spread out, because so much of the top end is driven by practice ownership, cosmetic cash revenue, and Mohs volume rather than seniority. A note on sources first: they disagree because they measure different things (W-2 payroll vs. total comp including owner profit and cosmetic revenue; employer-reported vs. self-reported). Treat BLS as the salaried floor, Physician Side Gigs' setting breakdown as the best guide to structure, and Doximity/Medscape as anchors for headline magnitude.910

National number. Depending on source and definition, derm lands anywhere from ~$323,530 (BLS payroll mean, W-2 only) to ~$508,401 (Doximity 2025 avg) and ~$513,000 (Physician Side Gigs self-report), with Medscape 2026 in between at ~$448,000 (a secondary summary of the same report cites ~$464K; ⟳ verify). A defensible "typical full-time" figure for 2025–26 is roughly $450,000–$510,000 total compensation, with owner/partner derms materially higher.9 ⟳

The spread (structure). The wRVU-based percentiles come from FastRVU's 2026 planning model, an aggregator's own educational product rather than a benchmark survey: median comp ~$426,000, at a median 7,900 wRVU/yr and $54 per wRVU (25th ~6,200 · 75th ~9,900 · 90th ~12,200 wRVU).11 The effective floor-to-ceiling runs from ~$350k (salaried, low-hours, or academic) to ~$700k+ (Mohs or owner-partner in a busy cosmetic-heavy practice), with outlier owners exceeding that.910 ⟳

Seniority matters less than ownership and setting. Early-career starting base runs ~$399k (Salary.com), with recruiter starting offers averaging ~$475k (Merritt Hawkins 2024); earnings of ~$480k+ are described as achievable within about six years of finishing residency.9 But the real lever is the practice model. W-2 employees average ~$495k against partners and owners at ~$667k, so ownership pays 35% more.10 Common extras: sign-on bonus (37% receive one; avg $32k, up to $100k), relocation ($11k), CME stipend ($3,900/yr).10 ⟳

Practice setting is the clearest map of derm pay (Physician Side Gigs 2024):10 ⟳

  • Solo private practice ~$658,000 · non-PE group ~$541,000 · PE-backed group ~$524,000 · non-academic hospital ~$466,000 · academic hospital ~$436,000 (the lowest).

The cosmetic cash-pay market, derm's signature economic quirk. A large slice of top-end derm income comes from fully cash-pay cosmetic procedures (Botox, fillers, lasers) that sit entirely outside the insurance system: no claims cycle, no payer discount, high gross margins. The US aesthetic injectable market was ~$4.1B (2024), ~$4.56B (2025), and is projected to reach ~$7.76B by 2030 (~11.2% CAGR), with botulinum toxin ~46% of it; the broader US/global medical-aesthetics market was ~$18.5B in 2024.8 This non-insurance revenue base is a big reason the $658k solo-practice and $667k partner averages sit so far above the wRVU and insurance baseline, because cosmetic-heavy practices blend medical and cash income. The catch: cosmetic demand concentrates in affluent metros, so the cash-pay upside is largely a big-city phenomenon.8 ⟳

The Mohs premium. Mohs micrographic surgery is the highest-paid derm subspecialty. Full-time Mohs surgeons average ~$710,000, roughly 35% above the overall derm average.12 FastRVU 2026 pegs Mohs at ~$580k–$680k against ~$420k–$480k for general derm, a premium of ~$160k–$200k a year, driven by high wRVU-per-procedure: Mohs Stage 1 (CPT 17311) = 8.50 wRVU, each added stage 4.25, versus a skin biopsy at ~1.07.12 ⟳

Geography. The pattern inverts the usual "big city pays most" intuition. Highest pay is in the Midwest and South (lower dermatologist density, high demand): PracticeLink/Medscape (May 2025) list Wisconsin, Indiana, Missouri, Georgia, and Nevada at the top (~$415k–$450k+), against a national ~$438k.13 Lowest base is in the high-density coastal states of California, New York, and Massachusetts, where metro oversupply depresses base pay. (ZipRecruiter's "top cities" list contradicts this by ranking CA/AK metros highest, but that's scraped nominal job-ad pay in high-cost areas rather than purchasing-power-adjusted comp; ⟳ verify.)13 ⟳

Urban vs. rural. Dermatology is oversupplied in desirable metros and scarce in rural/underserved areas, so rural roles carry a shortage premium in base pay, but with far less cash-pay cosmetic upside, since aesthetic demand concentrates in affluent metros. The high-paying-state pattern is the state-level expression of that same supply dynamic.13 ⟳

How you're actually paid. Increasingly by wRVU productivity (median ~$54/wRVU), often blended with cosmetic cash revenue and ownership distributions.11 BLS mean hourly wage is ~$156/hr, salaried only, so treat it as a floor.9 The per-hour standout is stark: Physician Side Gigs shows strong comp even at part-time-ish loads (26–30 hrs/wk ~$482k; 36–40 hrs ~$556k; 41–45 hrs ~$590k), which underpins derm's reputation as one of the best comp-per-hour specialties.10 Locum tenens runs ~$200–$300/hr; a full-time locum load (~16 days/mo at ~$290/hr) pencils out to ~$445k/yr.14 ⟳

Private-equity roll-ups, the defining recent trend. Dermatology has been a flagship target for PE consolidation, precisely because of its recurring visits, high cash-cosmetic margins, and historically fragmented ownership. In 2013–2016, dermatologists were ~1% of US physicians but 9.9% of PE physician investments; by 2023–2024, 10–15% of private derm practices were PE-backed, with 35+ PE platforms across 20 states (Forefront, PhyNet, Schweiger, QualDerm, DermCare, Advanced Dermatology & Cosmetic Surgery).15 The pay effect is visible in the setting data: PE-backed group comp ($524k) sits below non-PE group ($541k) and well below solo and partner ($658k–$667k), consistent with the classic PE trade, where selling physicians take a large upfront liquidity payout (a multiple of EBITDA) plus rollover equity, but younger/associate physicians hired after the sale typically earn less ongoing W-2 comp and don't capture ownership profit.1015 A 2021 Health Affairs study found PE-acquired practices had 3–5% higher reimbursement rates ~1.5 years post-acquisition but no significant change in total spending or procedure volume vs. peers; critics warn of volume and cosmetic/ancillary upselling pressure, while proponents cite preserved schedule/vacation control.15 ⟳

Lifestyle & the "D-in-ROAD" bargain

Dermatology is routinely described as one of the most controllable lifestyles in all of medicine, the reason it's the "D" people mentally swap into the ROAD mnemonic.1

  • Hours: typically ~35–45 clinical hours/week, among the lowest of any specialty; many derms build a true 4-day week or protected half-days.1
  • Call: minimal-to-essentially-none for most outpatient/private-practice derms. Dermatologic emergencies (Stevens-Johnson, DRESS, severe infections) exist but are rare, and inpatient consults fall mostly on academic and hospital-based derms, so there is little that can't wait until morning.1
  • Setting: overwhelmingly outpatient/clinic-based, with procedures done in-office under local anesthesia, so days are predictable and appointment-driven.1
  • Schedule control: very high, with a strong ability to set clinic hours, take vacation, go part-time, and build a practice around personal preference. Because pay-per-hour is high, part-time is genuinely financially viable, which makes derm attractive for parents and anyone prioritizing balance.1

Lifestyle rating: 5/5. High predictability and high control, the rare combination of top pay with defined hours and almost no call.

The honest caveats: the biggest real stressors in modern derm are high patient volume / short visit slots (some clinics push 40–60+ patients/day, which fatigues), prior-authorization friction for biologics, and the PE practice environment and its productivity pressure. The lifestyle is excellent without being frictionless.1

Wellbeing — the part to take seriously (mostly good news)

Burnout: below average on both instruments, and how far below depends on which one you read. The AMA's 2025 Organizational Biopsy, free, current and primary, puts dermatology at 31.5% against a 41.9% all-physician baseline, fifth lowest of the six specialties it names as least burned out.16 ⟳ Medscape's Physician Burnout & Depression Report 2024 measures the same thing on a different survey and finds a much smaller gap, dermatology at 46% against that report's 49% all-physician average, though neither freely readable summary of it prints dermatology's row.16 ⟳ The two are not interchangeable and their baselines are seven points apart, so a rank quoted without its survey means nothing. On Medscape's instrument this page used to say derm ran in the low-to-mid 30s and near the very bottom, which overstated the gap by ten to fifteen points; the AMA row is where a low-30s figure legitimately comes from. Derm's real wellbeing story is the balance measure rather than the burnout rank: the hours are controllable, the call is light, and almost nothing in the job arrives at 3 a.m.

Happiness and balance: high, on the measures that are still published. Derms report strong at-work and outside-of-work happiness, and on Medscape's 2025 "work-life balance is possible" measure dermatology ranked third at ~87%, behind only allergy/immunology and pathology.17 ⟳ A ~62% "happy outside work" figure also circulates for derm. Its only home is a Medscape 2024 lifestyle table that sits behind the paywall and is not carried by any of the free summaries that print the burnout rows, so it is not quoted here as a number.

The figure you will see most often is the one nobody publishes any more. "Would choose the specialty again" was retired by Medscape as a by-specialty measure around 2019, and the ~96% still attached to dermatology online is a revival of that table with no current publisher behind it. The balance measure above is a different question and is the one this page stands behind.17

Satisfaction drivers: controllable hours, high pay, low acute-emergency stress, visible and gratifying results (skin cancers cured, disfiguring or miserable conditions cleared), and a healthy mix of cognitive diagnosis plus hands-on procedures.18

Career longevity, the easy part. This is a real strength: low physical strain compared with surgical subspecialties, no overnight-call grind, and easy tapering to part-time make derm one of the easiest specialties to practice well into later career. Attrition is low.18

Who's in the field (demographics)

  • Women: 53% of practicing dermatologists (AAMC, 2022 data), above the all-specialty average of ~38%, and residents are more female still at 65.3% in AY2024-25, making derm one of the most female-majority specialties.19 ⟳
  • DO: low, at roughly ~7% of derm positions filled by DOs (2024 NRMP); the small categorical PGY-1 slice ran ~16.7% DO in 2025, but DO applicant match rates (~30% in 2026) are about half the US-MD rate.720 ⟳
  • IMG: very low, close to zero. 0 US IMGs and 1 non-US IMG matched PGY-1 derm in 2025. Derm is generally considered not IMG-friendly.720 ⟳
  • Race/ethnicity, and one of the least diverse specialties. Dermatology is frequently cited as the second least racially diverse specialty in medicine (after orthopedic surgery). Workforce data (~2019–20) put Black dermatologists at ~4.6% and Hispanic/Latinx at ~6.6% (American Indian/Alaska Native 0.7%; Native Hawaiian 0.2%), markedly below the US population at ~13.6% Black and ~19.5% Hispanic. In academic dermatology (2018), Black + Hispanic/Latinx combined were just 2.7%. The 2023–24 applicant pool was more diverse (9.5% Black, 4.8% Hispanic) than the matched/practicing workforce, implying URiM attrition at the match stage; a 2025 JAAD 5-year retrospective reports modest improvement but persistent gaps.21 ⟳

Culture, personality & the online stereotypes

Who gravitates here: visual, pattern-recognition thinkers who like "reading" morphology; detail-oriented, precise people who enjoy nuanced descriptive vocabulary, dermatopathology, and margin-precise procedures; those who want procedures without the OR grind (hands-on but controllable, done awake under local, no long call); entrepreneurial/business-minded types who like the idea of owning a practice or building a cosmetic line; and, as a structural reality, very high academic achievers, because the field self-selects for top-of-class students given how competitive it is. As always, plenty of people in the field do not fit any single mold.22

The stereotypes. Community caricatures rather than facts, each with an unfair edge:

  • "The lifestyle specialty for gunners." Reality: yes, it's competitive and lifestyle-favorable, but that framing ignores the genuine clinical draw and real intellectual depth of the field.
  • "Rich, cosmetic, vain: Botox and fillers." Reality: cosmetics is lucrative and real, but the bulk of dermatology is medical: skin cancer, autoimmune and inflammatory disease, pediatric derm, drug reactions, dermatologic emergencies. There's serious medical gravity behind the glossy image.
  • "Clique-y / impossible to break into." Partly structural, not personal: the competitiveness and reliance on mentorship and away rotations creates real access barriers, a fairness issue especially for FLI, DO, and IMG applicants, but the "vain clique" framing is a stereotype.
  • "Pimple poppers." A pop-culture reduction that trivializes a broad medical and surgical specialty.

What people say online (synthesized and paraphrased, not quotes): Across trainee and physician forums, derm is widely treated as the "dream" or "holy grail" specialty, top pay and best lifestyle, which fuels both admiration and resentment, with threads oscillating between envy and "you have no idea how hard it is to actually match." The recurring themes: the brutal competitiveness (near-perfect grades, AOA, huge research output) and, most pointedly, the sense that connections, mentorship, and "who you know" matter enormously, which many posters call the field's least meritocratic feature. There's steady frustration that the application is an arms race (research year, dozens of pubs, multiple away rotations) that disadvantages anyone without a home derm department or funded time. And there's growing, vocal concern about private-equity buyouts. Posters describe volume pressure, cosmetic/ancillary upselling, and productivity quotas, and debate PE-owned vs. private/academic jobs at length. Practicing derms who post generally report high satisfaction, naming good hours, engaging cases, and financial security, while calling out the volume treadmill and the insurance and prior-auth hassle as the real day-to-day irritants rather than the work itself.

Voices from the field. Paraphrased from public writing, with links to the originals:

  • A Medscape editorial frames dermatology as a standout for pairing top-tier compensation with unusually low stress and strong lifestyle, while noting rising demand and workforce shortages.23
  • The American Academy of Dermatology emphasizes derm's core identity as medical care for skin, hair, and nails, including skin-cancer detection and serious inflammatory disease, and advocates on workforce access and scope of practice.23
  • A JAAD analysis documents the rapid expansion of private-equity ownership in dermatology and raises pointed questions about its effects on autonomy, care patterns, and the specialty's future.23
  • A Clinics in Dermatology review "demystifies" the residency application process, laying out the academic-metric-and-connections arms race that defines derm competitiveness and its access implications.23

Why people choose it / why people leave

Why choose it: best-in-medicine blend of lifestyle, pay, and low stress · controllable hours and minimal call · intellectually rich visual diagnosis plus satisfying, immediate procedural work · real medical impact (skin cancer, serious autoimmune/inflammatory disease) alongside optional cosmetic/entrepreneurial upside · high job security · low burnout · excellent career longevity · easy part-time flexibility.

Why leave or avoid it: extreme, front-loaded competitiveness (the barrier is real) · high-volume "treadmill" clinics and short visit slots · insurance/prior-auth friction for biologics · private-equity consolidation squeezing autonomy and pushing productivity/cosmetic upselling · little acute/critical care or deep inpatient continuity if that's what you crave · repetitive high-throughput visits.

Best fit if: you're a strong visual/pattern learner who is detail-obsessed · you enjoy procedures but not overnight call · you value lifestyle and schedule control highly and are willing to run the competitive gauntlet · you like the mix of clinic medicine, minor surgery, pathology, and (optionally) business/aesthetics.

Not for you if: you want high-acuity, life-in-your-hands emergency or critical care · you want deep long-term continuity with sick hospitalized patients · you dislike repetitive, high-throughput outpatient volume · you aren't willing or positioned to invest heavily in research and connections during medical school.

The FLI angle — Dermatology for first-gen, low-income & immigrant students

The upside is enormous, and so is the barrier. Dermatology offers arguably the single best combination of pay and lifestyle in medicine, which for a first-gen/low-income/immigrant student means life-changing financial mobility with sustainable hours. But it is also one of the hardest specialties in all of medicine to break into, and its selection process structurally favors well-resourced applicants. Both halves of that sentence are true at once, and you have to plan around both.

Where derm rewards FLI students (if you can get in):

  • Exceptional, durable income with a controllable life. Top-tier pay earned in relatively few hours, with low burnout and long career longevity, the kind of stability that changes a family's trajectory.
  • Part-time is financially real. Because comp-per-hour is so high, working fewer hours later doesn't mean giving up a strong income, a genuine option for anyone carrying family responsibilities.101

Why the barrier hits FLI, DO, and IMG applicants hardest, named squarely:

  • The research/publication arms race. Matched applicants average ~28 abstracts/presentations/publications and ~6 research experiences.5 Building that typically requires a derm research lab, mentors who publish, and often an unpaid or self-funded dedicated research year, a luxury FLI students frequently cannot afford.
  • Connections and mentorship. The field is heavily relationship-driven. Applicants at schools without a home dermatology department (disproportionately DO students and those at less-resourced schools) start at a real disadvantage; who wrote your letters and who called for you matters.
  • Away ("audition") rotations. Multiple aways are near-expected, and each costs thousands in travel, housing, and lost income, which is a direct financial screen.
  • A metrics ceiling and a near-closed door. A very high Step 2 CK (matched mean ~257), AOA/top-class standing, and elite grades are the baseline; DO match rates run roughly half the US-MD rate, and derm is essentially not IMG-friendly (near-zero IMG entry).5720
  • The documented diversity gap. Derm is one of the least racially diverse specialties (Black ~4.6%, Hispanic ~6.6% of dermatologists), with URiM applicants attriting between the more diverse applicant pool and the matched class, a structural signal rather than a reflection of any individual's ability.21

How to approach it honestly (FLI strategy):

  • Decide early. Because the research/connection buildup takes years, commit in the first year or two of medical school (or earlier) if derm is a real target.
  • Find a mentor and a home department fast. And if your school lacks one, aggressively seek external mentorship and remote research collaborations.
  • Prioritize funded research (NIH/institutional fellowships, diversity- and access-focused programs) over self-funded time.
  • Use AAD/derm diversity pipelines and away-rotation scholarships. Several programs offer mentorship, visiting-elective scholarships, and diversity grants aimed specifically at under-resourced and underrepresented applicants, which can offset the away-rotation cost screen.
  • Have a strong backup plan. Given the odds, build a parallel path so a non-match isn't catastrophic.

Bottom line for FLI: the reward is exceptional, but the entry cost is paid in years of research, mentorship access, and away-rotation money, resources FLI students have less of. It is achievable, but it demands earlier commitment, deliberate mentorship-seeking, and use of every access and diversity program available. Go in with eyes open and a backup.

Subspecialties & fellowships

Most are 1-year fellowships; none is required to practice general dermatology.24

  • Micrographic Surgery & Dermatologic Oncology (Mohs / procedural derm). The most sought-after fellowship; margin-controlled skin-cancer surgery with high procedural volume and the top income in the field. Carries its own ABD subspecialty certification (MDS).
  • Dermatopathology. Microscopic diagnosis of skin biopsies, jointly boarded with pathology; low patient contact, diagnosis-focused, excellent lifestyle.
  • Pediatric Dermatology. Skin disease in children (genodermatoses, hemangiomas, pediatric eczema/psoriasis); mission-driven and in short supply.
  • Complex Medical Dermatology / Immunodermatology. Severe inflammatory, autoimmune, and connective-tissue skin disease and biologics management; often academic and inpatient-consult oriented (ABD certification status varies; ⟳ verify).
  • Cosmetic / Aesthetic / Laser Dermatology. Lasers, injectables, and procedural aesthetics; frequently built into a practice without a formal ACGME fellowship, with high cash-pay upside.
  • Also: pigmented-lesion/melanoma & cutaneous oncology, contact dermatitis/patch testing, and global/access dermatology.

Fun facts

  • Skin is the body's largest organ, and skin cancer is the most common cancer in the US. Derms are frontline cancer doctors rather than only cosmetic providers.
  • Mohs micrographic surgery lets a single physician act as surgeon and pathologist, examining ~100% of margins in real time, with cure rates up to ~99% on many skin cancers.
  • Dermatology consistently posts some of the highest work-life-balance scores in Medscape's annual reports. On burnout the two instruments that measure it disagree about the size of the gap while agreeing on its direction: ten points below average in the AMA's 2025 Organizational Biopsy (31.5% against 41.9%), three points below in Medscape's 2024 report (46% against 49%).
  • It's one of the few fields where you can be a diagnostician, a surgeon, and a pathologist in the same day.
  • The biologics revolution (psoriasis, atopic dermatitis, hidradenitis) has turned derm into a cutting-edge immunology specialty over the last decade.
  • Matched derm applicants average roughly 28 abstracts, presentations, and publications, among the highest research burdens of any specialty.

Sources

Footnotes

  1. Lifestyle — ~35–45 clinical hrs/wk (among the lowest); minimal-to-no call; outpatient/clinic-based; very high schedule control; volume/prior-auth/PE as main stressors. Synthesized from Medscape Physician Lifestyle Reports 2024/2025 and AAD, as compiled in the dermatology lifestyle research file. Medscape Lifestyle (https://www.medscape.com/sites/public/lifestyle/2024); AAD (https://www.aad.org). ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  2. Dermatology training pathway (1 intern year — transitional or prelim EM/FM/surgery/IM/OB-GYN/peds; not psych or path — + 3 derm years; advanced vs. categorical entry; ABD CORE + APPLIED exams). American Board of Dermatology, "Dermatology Training Pathway," 2026 (https://www.abderm.org/residents-and-fellows/residency-training/dermatology-training-pathway). ↩ ↩2 ↩3 ↩4

  3. NRMP, Results and Data: 2025 Main Residency Match (May 2025), dermatology tables — PGY-2 derm 524 positions/148 programs, 99.8% filled; PGY-1 30 positions, 100% filled (80.0% US MD, 16.7% US DO, 0% US IMG, 3.3% non-US IMG). https://www.nrmp.org/wp-content/uploads/2025/05/Main_Match_Results_and_Data_20250529_FINAL.pdf ↩ ↩2

  4. 2026 cycle outcomes. Positions and fill, from the primary: NRMP, Results and Data: 2026 Main Residency Match (May 2026), Table 1A, PGY-2 positions — dermatology 156 programs, 546 positions offered, 1 unfilled, 545 filled (99.8%), with 434 of the 546 positions going to US MD seniors (79.5%). https://www.nrmp.org/wp-content/uploads/2026/05/Main_Match_Results_and_Data-2026.pdf Applicant match rates by school type, which NRMP does not publish in that form: US MD 59%, US DO 30%, US IMG 38% (small n), non-US IMG 14%. MedEdits, "Dermatology Residency Match: Stats, Strategy and How to Match (2026-2027)" (https://mededits.com/mededits-resources/dermatology-residency-match-stats-strategy-and-how-to-match). ⟳ Corrected 2026-08-17: the position and fill figures were attributed to the aggregator and carried a note to verify them against the primary NRMP report "when released." That report was released in May 2026, and every figure the aggregator supplied is exact against Table 1A, so the attribution has moved to the primary while the numbers stand. MedEdits is kept only for the by-school-type applicant match rates. ↩ ↩2

  5. NRMP, Charting Outcomes in the Match: U.S. MD Seniors, 2024 (Aug 2024) — matched mean Step 2 CK 257 (unmatched 250); mean abstracts/presentations/publications 27.7 (unmatched 19.0); mean research experiences 6.4; AOA 41.1% matched vs 23.8%; top-40 NIH med school 41.7% vs 23.0%; PhD 9.8% vs 1.7%. https://www.nrmp.org/wp-content/uploads/2024/08/Charting_Outcomes_MD_Seniors_2024-2.pdf ; as summarized by Dermatology Times, "Match Day 2024," 2024 (https://www.dermatologytimes.com/view/match-day-2024-a-look-at-statistics-on-the-dermatology-match). ↩ ↩2 ↩3 ↩4 ↩5

  6. Applicant-to-position ratio ~1.5:1 historically (2022: 834 applicants / 544 positions = 1.53:1); ratio understates competitiveness due to self-selection. MedEdits, citing NRMP historical data (https://mededits.com/mededits-resources/dermatology-residency-match-stats-strategy-and-how-to-match). ↩

  7. DO/IMG accessibility — derm ~7% of PGY-1 positions filled by DOs (2024, among the least DO-friendly), near-zero IMG. (NRMP 2024 via yousmle, https://www.yousmle.com/do-match-rate-by-specialty/; NRMP 2025 Advance Data via matcharesident, https://blog.matcharesident.com/top-img-friendly-specialties-of-2025/). ⟳ verify against NRMP primary PDFs. ↩ ↩2 ↩3 ↩4

  8. Cash-pay cosmetic/aesthetic market — US aesthetic injectable market $4.1B (2024) → $4.56B (2025) → $7.76B projected 2030 (11.2% CAGR); botulinum toxin ~45.9% of market. Grand View Research (https://www.grandviewresearch.com/industry-analysis/us-aesthetic-injectable-market-report). Broader US/global medical aesthetics ~$18.48B (2024) → ~$55.99B (2033). DataM Intelligence via PRNewswire (https://www.prnewswire.com/news-releases/medical-aesthetics-market-to-surge-from-us-18-48-billion-in-2024-to-us-55-99-billion-by-2033-as-demand-for-non-invasive-cosmetic-procedures-explodes--datam-intelligence-302579864.html). ↩ ↩2 ↩3

  9. National compensation — Doximity 2025 Physician Compensation Report (avg $508,401; +3.7% YoY; 16th of all specialties), https://www.doximity.com/reports/physician-compensation-report/2025; Medscape Dermatologist Compensation Report 2026 ($448,000, 10th of 29; alt. secondary summary ~$464,000 — verify), via Becker's (https://www.beckershospitalreview.com/compensation-issues/29-physician-specialties-ranked-by-annual-compensation-medscape/) and nuaxia (https://www.nuaxia.com/post/medscape-dermatology-compensation-report-2026); BLS OEWS, Dermatologists (SOC 29-1213), May 2025 mean annual wage $323,530 and mean hourly wage $155.55, W-2 only; the same release puts the median at $328,730 and the 90th percentile at $578,560. US Bureau of Labor Statistics, Occupational Employment and Wages — May 2025, Table 1 (https://www.bls.gov/news.release/archives/ocwage_05152026.htm). Merritt Hawkins avg starting offer ~$475,000 (2024) via Barton Associates (https://www.bartonassociates.com/dermatologist-salary-guide/). Corrected 2026-08-17: the BLS mean on this page read $349,026, in the compensation lede and again here. That figure is Barton Associates' restatement and it runs $1,216 above the $347,810 the Bureau itself publishes for May 2024. The number now comes from the release directly, and the $167 hourly figure it was paired with is the Bureau's $167.22. Nothing else on the page moves. Updated 2026-08-18: the Bureau's May 2025 release, published 2026-05-15, superseded those May 2024 figures. The dermatology mean fell to $323,530 and the mean hourly wage to $155.55, and the compensation section above now carries both. That release also publishes a median and upper percentiles for the physician occupations, which the May 2024 release withheld. ↩ ↩2 ↩3 ↩4 ↩5

  10. Compensation by setting, employment model, hours, bonuses, and gender — Physician Side Gigs 2024 survey (self-reported, n=73): overall avg $513,000 / median $490,000; W-2 $495k vs partner/owner $667k (~35% more); solo $658k, non-PE group $541k, PE group $524k, non-academic hospital $466k, academic $436k; part-time (16–30 hrs) $475k, full-time (31+) $527k; comp by hours 26–30 $482k / 36–40 $556k / 41–45 $590k; sign-on 37% avg $32k, relocation 25% avg $11k, CME 59% avg $3,900. https://www.physiciansidegigs.com/average-dermatologist-salary. ⟳ verify — small sample. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8

  11. wRVU productivity/percentiles — FastRVU 2026: median comp $426,000; median 7,900 wRVU; $54/wRVU; 25th 6,200 / 75th 9,900 / 90th 12,200; Mohs Stage 1 (17311) 8.50 wRVU, skin biopsy (11100) 1.07 wRVU. https://fastrvu.com/specialties/dermatology Corrected 2026-08-17: this note and the body both described these figures as coming "from MGMA/Medscape/CMS." FastRVU names those bodies only to disclaim them — its page reads "Not produced by MGMA, AMGA, SullivanCotter, CMS, or AMA" and calls its own numbers survey-based planning references. The numbers were copied accurately; the publisher was not, and the borrowed authority is the defect. The attribution is removed from both surfaces. Corrected 2026-08-17: the figures stay and the host is now named in the visible sentence rather than only here, so a reader learns what the percentiles rest on at the point they read them. A figure of this kind is kept with its host named rather than removed, which extends this site's aggregator rule to the excluded-aggregator row: an aggregator's number is worth more displayed with its provenance than deleted with nothing to replace it. ↩ ↩2

  12. Mohs premium — full-time Mohs surgeons avg $710,000 (~35% above overall derm avg), Physician Side Gigs 2024 (https://www.physiciansidegigs.com/average-dermatologist-salary); FastRVU 2026 Mohs $580k–$680k vs general derm $420k–$480k (https://fastrvu.com/specialties/dermatology). Corrected 2026-08-17: the Mohs premium sentence already named FastRVU in the body and is left as it stands; see 11 for the decision and for the MGMA attribution removed from the percentile figures. ↩ ↩2

  13. Geography — highest-paying states Wisconsin/Indiana/Missouri/Georgia/Nevada (~$415k–$450k+; national ~$438k), lowest CA/NY/MA; rural shortage premium in base pay. PracticeLink (May 2025, citing Medscape), https://www.practicelink.com/resource-center/physician-next-practice/dermatology-salary-by-state/. ZipRecruiter city data (CA/AK metros highest) noted as scraped job-ad data — ⟳ verify; via physiciansthrive (https://physiciansthrive.com/physician-compensation/dermatologist-salary/). ↩ ↩2 ↩3

  14. Locum tenens ~$200–$300/hr; full-time locum (16 days/mo @ ~$290/hr) ≈ $445,000/yr; hybrid ≈ $533,000. Barton Associates/Sermo 2025 (https://www.bartonassociates.com/dermatologist-salary-guide/). ↩

  15. Private-equity consolidation — 2013–16 derms ~1% of physicians but ~9.9% of PE investments; 2023–24 ~10–15% of private practices PE-backed, 35+ platforms across ~20 states (Forefront, PhyNet, Schweiger, QualDerm, DermCare, Advanced Dermatology & Cosmetic Surgery); pay effect (PE group $524k < non-PE $541k < solo/partner $658k–$667k). Healio, "Private Equity in Dermatology" (2025), https://www.healio.com/news/dermatology/20250416/private-equity-in-dermatology-consolidation-modernization-are-on-the-horizon; Physician Growth Partners, "State of Dermatology Private Equity, Summer 2024," https://physiciangrowthpartners.com/white-paper/state-of-dermatology-private-equity-summer-2024/; Health Affairs 2021 (3–5% higher reimbursement post-acquisition), https://www.healthaffairs.org/doi/10.1377/hlthaff.2020.02062. JAAD, "Landscape of Private Equity in Dermatology" (2023), https://www.jaad.org/article/S0190-9622(23)02101-1/fulltext. ↩ ↩2 ↩3

  16. Burnout. Corrected 2026-08-17: the dashboard and the body now lead with the AMA row, 31.5% against a 41.9% all-physician average, and the Medscape reading follows against its own 49% baseline. AMA is the instrument this page prefers wherever it publishes a row, because it is free, primary and current, and dermatology is one of the roughly fifteen it breaks out. The dashboard no longer carries both figures side by side. The Medscape reading, kept in the body: dermatology 46%, against a 49% all-physician average, with plastic surgery 37%, psychiatry and ophthalmology 39%, pathology 41%, otolaryngology 43% below it and emergency medicine highest at 63%. Medscape Physician Burnout & Depression Report 2024 (n=9,226, fielded July–October 2023). The report is paywalled. Neither free summary of it prints dermatology's row. Healthgrades Pro (https://resources.healthgrades.com/pro/the-most-and-least-burned-out-physicians-by-specialty) prints only the ten highest and the ten lowest of the 26 specialties it says the survey covered, and dermatology is in neither list; Advisory Board (https://www.advisory.com/daily-briefing/2024/01/31/physician-burnout) prints six specialties plus the 49% average. Together they bound the 46% without stating it: dermatology's absence from a bottom ten whose highest member is 45% means its figure must be above 45%, which is consistent with 46%. Treat the 46% itself as a figure this page inherited from the report and cannot check at source. Corrected 2026-08-17: this footnote said the table came from "three independent relays that agree on the edition, the instrument and every row" and then named two, neither of which carries dermatology. It also gave dermatology as "11th lowest of 25 ranked specialties"; no free summary ranks 25, and the rank is an inference from the two lists rather than a published position, so it has been removed from the footnote, the body and the dashboard. Correction, 2026-08-13: this page previously said derm ran in the low-to-mid 30s and sat near the very bottom of the table, in three places. ⟳ The second instrument, and the one that is primary here (its 2025 report): the AMA's Organizational Biopsy, nearly 19,000 physicians across 38 states and 106 health systems, puts Dermatology at 31.5% against a 41.9% all-physician average, fifth lowest of the six specialties it names as lowest, https://www.ama-assn.org/practice-management/physician-health/these-9-physician-specialties-report-highest-burnout-rates. Its baseline sits seven points below Medscape's 49% — the two never belong in the same sentence, and a cross-specialty rank must name which survey it comes from. ↩ ↩2

  17. Happiness & would-choose-again — derm ~87% "work-life balance possible" (Medscape 2025, ~3rd highest); "would choose specialty again" historically near the top (~96%, verify). Corrected 2026-08-17: this footnote also stated "derm ~62% happy outside work (Medscape 2024)" as a figure, while the body sentence beside it said the same 62% is deliberately not quoted because its only home is a paywalled lifestyle table. A reader following the marker saw the number the sentence said was being withheld. The figure is removed rather than re-sourced; nothing freely readable prints it. Medscape via HCN/Healthgrades; Medscape Compensation Report (annual), https://www.medscape.com/sites/public/mental-health/2025. ⟳ verify current-year figures. ↩ ↩2

  18. Satisfaction drivers & career longevity — controllable hours, high pay, low acute stress, gratifying results; low physical strain, no overnight call, easy taper to part-time, low attrition. Dermatology lifestyle research file, synthesized from Medscape/AAD and community sentiment. https://www.medscape.com/viewarticle/high-pay-low-stress-dermatology-boom-2025a10002c4 ↩ ↩2

  19. Women in dermatology. Practicing, 53%: AAMC, "Women are changing the face of medicine in America" (2022 data), https://www.aamc.org/news/women-are-changing-face-medicine-america. Residents, 65.3% in AY2024-25: ACGME, Data Resource Book, Academic Year 2024-2025, Table C.21, https://www.acgme.org/globalassets/pfassets/publicationsbooks/2024-2025_acgme_databook_document.pdf. Corrected 2026-08-13: this page carried "~51–53% practicing" as a range and "~60% of residents" with a note to verify the exact figure, five points below the published count. ⟳ ↩

  20. Medical-school-of-origin of derm trainees — ~80% US MD; DO ~7% of positions (small categorical slice ~16.7% in 2025; DO applicant match ~30% in 2026); IMG near-zero (0 US IMG, 1 non-US IMG PGY-1, 2025). NRMP 2025 Results & Data (URL in 3); MedEdits 2026 (URL in 4). ↩ ↩2 ↩3

  21. Race/ethnicity — derm frequently cited as second least diverse specialty (after orthopedics); Black ~4.6%, Hispanic/Latinx ~6.6%, AI/AN 0.7%, NH 0.2% of dermatologists (~2019–20); academic derm 2018 Black+Hispanic combined 2.7%; 2023–24 applicant pool 9.5% Black, 4.8% Hispanic (more diverse than matched pool). Pandya et al., "Why dermatology is the second least diverse specialty," ScienceDirect 2020 (https://www.sciencedirect.com/science/article/abs/pii/S0738081X20300304); AJMC, "Racial, Ethnic Disparities Persist in Dermatology" (https://www.ajmc.com/view/racial-ethnic-disparities-persist-in-dermatology-research-and-in-workforce); Springer, Arch Dermatol Res, "Examining dermatology residency applicant profiles for the 2023–2024 cycle," 2024 (https://link.springer.com/article/10.1007/s00403-024-03470-7); JAAD, "Advancements in diversity in dermatology: A 5-year retrospective (2020–2024)," 2025 (https://www.jaad.org/article/S0190-9622(25)02116-4/fulltext). ⟳ verify exact figures. ↩ ↩2

  22. Who gravitates / personality — visual pattern-recognition thinkers, detail-oriented, procedures-without-OR, entrepreneurial/cosmetic-inclined, high academic achievers. Dermatology lifestyle/culture research file, synthesized from AAD and community forums (paraphrased). ↩

  23. Sourced voices — Medscape editorial, "High Pay, Low Stress: The Dermatology Boom" (2025), https://www.medscape.com/viewarticle/high-pay-low-stress-dermatology-boom-2025a10002c4; American Academy of Dermatology / AADA, https://www.aad.org; JAAD, "Landscape of Private Equity in Dermatology" (2023), https://www.jaad.org/article/S0190-9622(23)02101-1/fulltext; Clinics in Dermatology / ScienceDirect, "Demystifying the dermatology residency application process" (2025), https://www.sciencedirect.com/science/article/abs/pii/S0738081X25001841. ↩ ↩2 ↩3 ↩4

  24. Fellowships/subspecialties — Mohs/MSDO (MDS certification), dermatopathology (joint ABD/ABP), pediatric dermatology, complex medical dermatology, cosmetic/laser. ABD Fellowship Training pages, 2026 (https://www.abderm.org/residents-and-fellows/fellowship-training/micrographic-surgery-and-dermatologic-oncology; https://www.abderm.org/residents-and-fellows/fellowship-training/dermatopathology); MDedge, "Fellowships After Dermatology Residency" (https://www.mdedge.com/content/fellowships-after-dermatology-residency-traditional-and-beyond). ↩

Researched with AI assistance and reviewed by hand. How this site is made